Pharmacogenetics – legal, ethical and regulatory considerations
- 4 November 2001
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 2 (4) , 317-327
- https://doi.org/10.1517/14622416.2.4.317
Abstract
The overall objective of pharmacogenetics is to determine the genetic basis of variability in drug efficacy and safety, and to use this information to benefit the patient. Genetics can be used to develop drugs that are suitable for the majority of patients and to help identify those patients for whom a certain drug may not be the most appropriate. This review will cover some background to pharmacogenetics and various issues including confidentiality, data protection, coding of samples and genetic data, informed consent, and drug development guidelines. International, national and regional variation in the legal and regulatory basis for pharmacogenetics presents challenges for researchers attempting to increase scientific understanding in the field. Examples of national and international regulations and guidelines will be given. It is clear that pharmacogenetics today is a long way from the ‘personalised medicine’ advocated by some individuals in recent years. The aim of pharmacogenetic research should alw...Keywords
This publication has 13 references indexed in Scilit:
- Clinical application of pharmacogeneticsTrends in Molecular Medicine, 2001
- Effect of Polymorphism of the β2-Adrenergic Receptor on Response to Regular Use of Albuterol in AsthmaInternational Archives of Allergy and Immunology, 2001
- Terminology for sample collection in clinical genetic studiesThe Pharmacogenomics Journal, 2001
- Molecular Diagnosis of CYP21 Mutations in Congenital Adrenal HyperplasiaAmerican Journal of PharmacoGenomics, 2001
- Genetic Variation as a Guide to Drug DevelopmentScience, 1998
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998
- The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 1998
- Getting the right drug into the right patientNature Biotechnology, 1997
- MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISMAnnual Review of Pharmacology and Toxicology, 1997
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990